サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1478538

遺伝子導入技術の世界市場2033年までの機会と戦略

Gene Delivery Technologies Global Market Opportunities And Strategies To 2033
出版日: | 発行: The Business Research Company | ページ情報: 英文 290 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=150.67円
遺伝子導入技術の世界市場2033年までの機会と戦略
出版日: 2024年05月13日
発行: The Business Research Company
ページ情報: 英文 290 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 目次
概要

世界の遺伝子導入技術市場は2018年に21億5,964万米ドルと評価され、2023年までCAGR8.0％以上で成長しました。

研究開発への投資の増加

実績期間において、遺伝子導入技術市場は主に研究開発への投資の拡大によって牽引されました。研究開発（R&D）への投資は、技術の進歩、国際競争、市場需要、規制圧力、世界の課題、資本へのアクセス、長期的な成長と競合の主要促進要因としての研究開発の認識などにより増加しています。このような投資は、新しいデリバリーシステムの開発、ターゲティング能力の向上、安全性プロファイルの改善、応用範囲の拡大などを可能にすることにより、遺伝子導入技術に役立っており、最終的には、遺伝性疾患やがんなど、さまざまな疾患に対するより効果的で個別化された治療につながります。例えば、米国の政府機関National Center for Science and Engineering Statisticsによると、2022年、州政府機関は研究・実験開発（R&D）に総額26億4,400万米ドルを支出したと報告しています。これは、前年度の25億1,300万米ドルから5.2％の増加です。従って、研究開発への投資の拡大は遺伝子導入技術市場の成長に寄与しました。

目次

第1章 エグゼクティブサマリー

  • 遺伝子送達技術-市場の魅力とマクロ経済情勢

第2章 目次

第3章 目次

第4章 表一覧

第5章 レポートの構造

第6章 市場の特徴

  • 一般的な市場の定義
  • 概要
  • 遺伝子導入技術市場定義とセグメンテーション
  • 市場セグメンテーション：モード別
    • 生物学的
    • 化学的
    • 物理的
  • 市場セグメンテーション：方法別
    • 生体外
    • In vivo
    • In vitro
  • 市場セグメンテーション：用途別
    • 遺伝子治療
    • 細胞療法
    • ワクチン
    • 研究

第7章 主要な市場動向

  • 遺伝子編集技術を向上させる革新的な進歩
  • 鎌状赤血球症に対する画期的な遺伝子治療の承認：カスゲビーの革命的な影響
  • 遺伝子送達技術の進歩を促進する戦略的投資
  • 遺伝子治療の促進に向けた提携と買収の増加

第8章 遺伝子導入技術市場-マクロ経済シナリオ

  • COVID-19の影響遺伝子導入技術市場
  • ウクライナ戦争の影響、遺伝子導入技術市場
  • 高インフレの影響遺伝子導入技術市場

第9章 世界の市場規模と成長

  • 市場規模
  • 市場成長実績、2018～2023年
    • 市場促進要因、2018～2023年
    • 市場抑制要因、2018～2023年
  • 予測市場成長、2023～2028年、2033年
    • 市場促進要因、2023～2028年
    • 市場抑制要因、2023～2028年

第10章 世界の遺伝子導入技術市場：セグメンテーション

  • 世界の遺伝子導入技術市場：モード別、実績と予測、2018～2023年、2028年、2033年
  • 世界の遺伝子導入技術市場：方法別、実績と予測、2018～2023年、2028年、2033年
  • 世界の遺伝子導入技術市場：用途別、実績と予測、2018～2023年、2028年、2033年

第11章 遺伝子導入技術市場：地域・国別分析

  • 世界の遺伝子導入技術市場：地域別、実績と予測、2018～2023年、2028年、2033年
  • 世界の遺伝子導入技術市場：国別、実績と予測、2018～2023年、2028年、2033年

第12章 アジア太平洋市場

第13章 西欧市場

第14章 東欧市場

第15章 北米市場

第16章 南米市場

第17章 中東市場

第18章 アフリカ市場

第19章 競合情勢と企業プロファイル

  • 企業プロファイル
  • Horizon Discovery Group Co
  • Bio-Rad Laboratories, Inc.
  • Promega Corporation
  • OriGene Technologies Inc.
  • Takara Bio Inc.

第20章 競合ベンチマーキング

第21章 競合ダッシュボード

第22章 主要な合併と買収

  • Tectonic Therapeutic Merged With AVROBIO
  • Kyowa Kirin Acquired Orchard Therapeutics
  • Syncona Acquired Applied Genetic Technologies Corp.
  • Eli Lilly Acquired Akouos
  • Eli Lilly Acquired Prevail Therapeutics

第23章 機会と戦略

  • 世界の遺伝子導入技術市場、2028年：新規事業機会の多い国
  • 世界の遺伝子導入技術市場、2028年：新規事業機会の多いセグメント
  • 世界の遺伝子導入技術市場、2028年：成長戦略
    • 市場動向別の戦略
    • 競合の戦略

第24章 遺伝子導入技術市場：結論と提言

  • 結論
  • 推奨事項
    • 製品
    • 場所
    • 価格
    • プロモーション
    • 人材

第25章 付録

目次
Product Code: o&s1137

Gene delivery technologies encompass a diverse range of methods utilized to introduce genetic material into target cells or organisms for various applications, including gene therapy, genetic engineering and research purposes. These technologies are crucial for manipulating genetic information, enabling the delivery of therapeutic genes, gene editing tools or genetic constructs into cells to modulate gene expression or correct genetic defects.

The gene delivery technologies market consists of revenues earned by entities (organizations, sole traders or partnerships) primarily engaged in the development, production and distribution of techniques and systems for delivering genetic material. These technologies find extensive applications in biopharmaceuticals, agriculture, research and other fields.

The global gene delivery technologies market was valued at $2,159.64 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 8.0%.

Growing Investments In Research And Development

During the historic period, the gene delivery technologies market was mainly driven by the growing investments in research and development. The investment in research and development (R&D) is growing due to technological advancements, global competition, market demand, regulatory pressures, global challenges, access to capital and the recognition of R&D as a key driver of long-term growth and competitiveness. This investment helps gene delivery technologies by enabling the development of new and improved delivery systems, enhancing targeting capabilities, improving safety profiles and expanding the range of applications, ultimately leading to more effective and personalized treatments for various diseases, including genetic disorders and cancer. For instance, according to the National Center for Science and Engineering Statistics, a US-based government agency, in 2022, state government agencies reported a total expenditure of $2.644 billion on research and experimental development (R&D). This represents a 5.2% increase from the previous year's expenditures of $2.513 billion. Therefore, growing investments in research and development contributed to the growth of the gene delivery technologies market.

Innovative Advancements To Improve Gene-Editing Technologies

Companies in the gene delivery technologies market are developing innovative products such as QIAprep& CRISPR Kit to provide rapid and sensitive characterization of clustered regularly interspaced short palindromic repeats (CRISPR)-based genome editing events in mouse or rat cells. The QIAprep& CRISPR Kit offers a streamlined workflow that includes liquid-based sample preparation, custom primer design, amplification of the region of interest and quantification of editing efficiency. For instance, in June 2021, Qiagen, a Germany-based genomics company, launched QIAprep& CRISPR Kit. This launch by QIAGEN represents a significant advancement in gene-editing technologies, providing researchers with efficient tools for analyzing and characterizing gene-editing events with high precision and sensitivity.

The global gene delivery technologies market is highly concentrated, with large players operating in the market. The top ten competitors in the market made up to 67.3% of the total market in 2022.

Gene Delivery Technologies Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global gene delivery technologies market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for gene delivery technologies market? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The gene delivery technologies market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider gene delivery technologies market; and compares it with other markets.

The report covers the following chapters

  • Introduction And Market Characteristics - Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by mode, by method and by application.
  • Key Trends - Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the gene delivery technologies market.
  • Global Market Size and Growth - Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional And Country Analysis - Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.

Market Segmentation - Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by mode, by method and by application in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.

  • Regional Market Size And Growth - Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape - Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Competitive Benchmarking - Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard - Briefs on competitive dashboard of major players.
  • Key Mergers And Acquisitions - Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
  • Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations- This section includes recommendations for gene delivery technologies providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Scope

Markets Covered:

  • 1) By Mode: Biological; Chemical; Physical
  • 2) By Application: Gene Therapy; Cell Therapy; Vaccines; Research
  • 3) By Method: Ex Vivo; In Vivo; In Vitro
  • Companies Mentioned: Horizon Discovery Group Co; Bio-Rad Laboratories Inc.; Promega Corporation; OriGene Technologies Inc.; Takara Bio Inc.
  • Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Brazil; Canada; France; Germany; UK; Italy; Spain; Russia
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time-series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; gene delivery technologies indicators comparison.
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

  • 1.1 Gene Delivery Technologies - Market Attractiveness And Macro economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

  • 6.1 General Market Definition
  • 6.2 Summary
  • 6.3 Gene Delivery Technologies Market Definition And Segmentations
  • 6.4 Market Segmentation By Mode
    • 6.4.1 Biological
    • 6.4.2 Chemical
    • 6.4.3 Physical
  • 6.5 Market Segmentation By Method
    • 6.5.1 Ex Vivo
    • 6.5.2 In Vivo
    • 6.5.3 In Vitro
  • 6.6 Market Segmentation By Application
    • 6.6.1 Gene Therapy
    • 6.6.2 Cell Therapy
    • 6.6.3 Vaccines
    • 6.6.4 Research

7 Major Market Trends

  • 7.1 Innovative Advancements To Improve Gene-Editing Technologies
  • 7.2 Breakthrough Gene Therapy Approval For Sickle Cell Disease: Casgevy's Revolutionary Impact
  • 7.3 Strategic Investments Fueling Advancements In Gene Delivery Technologies
  • 7.4 Increasing Partnerships And Acquisitions For Promoting Gene Therapy

8 Gene Delivery Technologies Market - Macro-Economic Scenario

  • 8.1 COVID-19 Impact On The Gene Delivery Technologies Market
  • 8.2 Impact Of The War In Ukraine On The Gene Delivery Technologies Market
  • 8.3 Impact Of High Inflation On The Gene Delivery Technologies Market

9 Global Market Size and Growth

  • 9.1 Market Size
  • 9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
    • 9.2.1 Market Drivers 2018 - 2023
    • 9.2.2 Market Restraints 2018 - 2023
  • 9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
    • 9.3.1 Market Drivers 2023 - 2028
    • 9.3.2 Market Restraints 2023 - 2028

10 Global Gene Delivery Technologies Market Segmentation

  • 10.1 Global Gene Delivery Technologies Market, Segmentation By Mode, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.2 Global Gene Delivery Technologies Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.3 Global Gene Delivery Technologies Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

11 Gene Delivery Technologies Market, Regional and Country Analysis

  • 11.1 Global Gene Delivery Technologies Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 11.2 Global Gene Delivery Technologies Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

  • 12.1 Summary
    • 12.1.1 Market Overview
    • 12.1.2 Region Information
    • 12.1.3 Market Information
    • 12.1.4 Background Information
    • 12.1.5 Government Initiatives
    • 12.1.6 Regulations
    • 12.1.7 Regulatory Bodies
    • 12.1.8 Major Associations
    • 12.1.9 Taxes Levied
    • 12.1.10 Corporate Tax Structure
    • 12.1.11 Investments
    • 12.1.12 Major Companies
  • 12.2 Asia-Pacific Gene Delivery Technologies Market, Segmentation By Mode, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.3 Asia-Pacific Gene Delivery Technologies Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.4 Asia-Pacific Gene Delivery Technologies Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.5 Asia-Pacific Gene Delivery Technologies Market: Country Analysis
  • 12.6 China Market
  • 12.7 Summary
    • 12.7.1 Market Overview
    • 12.7.2 Country Information
    • 12.7.3 Market Information
    • 12.7.4 Background Information
    • 12.7.5 Government Initiatives
    • 12.7.6 Regulations
    • 12.7.7 Regulatory Bodies
    • 12.7.8 Major Associations
    • 12.7.9 Taxes Levied
    • 12.7.10 Corporate Tax Structure
    • 12.7.11 Investments
    • 12.7.12 Major Companies
  • 12.8 China Gene Delivery Technologies Market, Segmentation By Mode, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.9 China Gene Delivery Technologies Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.10 China Gene Delivery Technologies Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.11 India Market
  • 12.12 India Gene Delivery Technologies Market, Segmentation By Mode, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.13 India Gene Delivery Technologies Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.14 India Gene Delivery Technologies Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.15 Japan Market
  • 12.16 Japan Gene Delivery Technologies Market, Segmentation By Mode, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.17 Japan Gene Delivery Technologies Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.18 Japan Gene Delivery Technologies Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.19 Australia Market
  • 12.20 Australia Gene Delivery Technologies Market, Segmentation By Mode, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.21 Australia Gene Delivery Technologies Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.22 Australia Gene Delivery Technologies Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.23 Indonesia Market
  • 12.24 Indonesia Gene Delivery Technologies Market, Segmentation By Mode, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.25 Indonesia Gene Delivery Technologies Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.26 Indonesia Gene Delivery Technologies Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.27 South Korea Market
  • 12.28 South Korea Gene Delivery Technologies Market, Segmentation By Mode, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.29 South Korea Gene Delivery Technologies Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.30 South Korea Gene Delivery Technologies Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

  • 13.1 Summary
    • 13.1.1 Market Overview
    • 13.1.2 Region Information
    • 13.1.3 Market Information
    • 13.1.4 Background Information
    • 13.1.5 Government Initiatives
    • 13.1.6 Regulations
    • 13.1.7 Regulatory Bodies
    • 13.1.8 Major Associations
    • 13.1.9 Taxes Levied
    • 13.1.10 Corporate tax structure
    • 13.1.11 Investments
    • 13.1.12 Major Companies
  • 13.2 Western Europe Gene Delivery Technologies Market, Segmentation By Mode, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.3 Western Europe Gene Delivery Technologies Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.4 Western Europe Gene Delivery Technologies Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.5 Western Europe Gene Delivery Technologies Market: Country Analysis
  • 13.6 UK Market
  • 13.7 UK Gene Delivery Technologies Market, Segmentation By Mode, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.8 UK Gene Delivery Technologies Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.9 UK Gene Delivery Technologies Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.10 Germany Market
  • 13.11 Germany Gene Delivery Technologies Market, Segmentation By Mode, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.12 Germany Gene Delivery Technologies Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.13 Germany Gene Delivery Technologies Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.14 France Market
  • 13.15 France Gene Delivery Technologies Market, Segmentation By Mode, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.16 France Gene Delivery Technologies Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.17 France Gene Delivery Technologies Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.18 Italy Market
  • 13.19 Italy Gene Delivery Technologies Market, Segmentation By Mode, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.20 Italy Gene Delivery Technologies Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.21 Italy Gene Delivery Technologies Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.22 Spain Market
  • 13.23 Spain Gene Delivery Technologies Market, Segmentation By Mode, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.24 Spain Gene Delivery Technologies Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.25 Spain Gene Delivery Technologies Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

  • 14.1 Summary
    • 14.1.1 Market Overview
    • 14.1.2 Region Information
    • 14.1.3 Market Information
    • 14.1.4 Background Information
    • 14.1.5 Government Initiatives
    • 14.1.6 Regulations
    • 14.1.7 Regulatory Bodies
    • 14.1.8 Major Associations
    • 14.1.9 Taxes Levied
    • 14.1.10 Corporate Tax Structure
    • 14.1.11 Major Companies
  • 14.2 Eastern Europe Gene Delivery Technologies Market, Segmentation By Mode, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.3 Eastern Europe Gene Delivery Technologies Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.4 Eastern Europe Gene Delivery Technologies Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.5 Eastern Europe Gene Delivery Technologies Market: Country Analysis
  • 14.6 Russia Market
  • 14.7 Russia Gene Delivery Technologies Market, Segmentation By Mode, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.8 Russia Gene Delivery Technologies Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.9 Russia Gene Delivery Technologies Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

  • 15.1 Summary
    • 15.1.1 Market Overview
    • 15.1.2 Region Information
    • 15.1.3 Market Information
    • 15.1.4 Background Information
    • 15.1.5 Government Initiatives
    • 15.1.6 Regulations
    • 15.1.7 Regulatory Bodies
    • 15.1.8 Major Associations
    • 15.1.9 Taxes Levied
    • 15.1.10 Corporate Tax Structure
    • 15.1.11 Investments
    • 15.1.12 Major Companies
  • 15.2 North America Gene Delivery Technologies Market, Segmentation By Mode, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.3 North America Gene Delivery Technologies Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.4 North America Gene Delivery Technologies Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.5 North America Gene Delivery Technologies Market: Country Analysis
  • 15.6 USA Market
  • 15.7 Summary
    • 15.7.1 Market Overview
    • 15.7.2 Country Information
    • 15.7.3 Market Information
    • 15.7.4 Background Information
    • 15.7.5 Government Initiatives
    • 15.7.6 Regulations
    • 15.7.7 Regulatory Bodies
    • 15.7.8 Major Associations
    • 15.7.9 Taxes Levied
    • 15.7.10 Corporate Tax Structure
    • 15.7.11 Investments
    • 15.7.12 Major Companies
  • 15.8 USA Gene Delivery Technologies Market, Segmentation By Mode, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.9 USA Gene Delivery Technologies Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.10 USA Gene Delivery Technologies Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.11 Canada Market
  • 15.12 Canada Gene Delivery Technologies Market, Segmentation By Mode, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.13 Canada Gene Delivery Technologies Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.14 Canada Gene Delivery Technologies Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

  • 16.1 Summary
    • 16.1.1 Market Overview
    • 16.1.2 Region Information
    • 16.1.3 Market Information
    • 16.1.4 Background Information
    • 16.1.5 Government Initiatives
    • 16.1.6 Regulations
    • 16.1.7 Regulatory Bodies
    • 16.1.8 Major Associations
    • 16.1.9 Taxes Levied
    • 16.1.10 Corporate Tax Structure
    • 16.1.11 Investments
    • 16.1.12 Major Companies
  • 16.2 South America Gene Delivery Technologies Market, Segmentation By Mode, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.3 South America Gene Delivery Technologies Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.4 South America Gene Delivery Technologies Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.5 South America Gene Delivery Technologies Market: Country Analysis
  • 16.6 Brazil Market
  • 16.7 Brazil Gene Delivery Technologies Market, Segmentation By Mode, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.8 Brazil Gene Delivery Technologies Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.9 Brazil Gene Delivery Technologies Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

  • 17.1 Summary
    • 17.1.1 Market Overview
    • 17.1.2 Region Information
    • 17.1.3 Market Information
    • 17.1.4 Background Information
    • 17.1.5 Government Initiatives
    • 17.1.6 Regulations
    • 17.1.7 Regulatory Bodies
    • 17.1.8 Major Associations
    • 17.1.9 Taxes Levied
    • 17.1.10 Corporate Tax Structure
    • 17.1.11 Major Companies
  • 17.2 Middle East Gene Delivery Technologies Market, Segmentation By Mode, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.3 Middle East Gene Delivery Technologies Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.4 Middle East Gene Delivery Technologies Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

  • 18.1 Summary
    • 18.1.1 Market Overview
    • 18.1.2 Region Information
    • 18.1.3 Market Information
    • 18.1.4 Background Information
    • 18.1.5 Government Initiatives
    • 18.1.6 Regulations
    • 18.1.7 Regulatory Bodies
    • 18.1.8 Major Associations
    • 18.1.9 Taxes Levied
    • 18.1.10 Corporate Tax Structure
    • 18.1.11 Major Companies
  • 18.2 Africa Gene Delivery Technologies Market, Segmentation By Mode, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.3 Africa Gene Delivery Technologies Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.4 Africa Gene Delivery Technologies Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape And Company Profiles

  • 19.1 Company Profiles
  • 19.2 Horizon Discovery Group Co
    • 19.2.1 Company Overview
    • 19.2.2 Products And Services
    • 19.2.3 Business Strategy
    • 19.2.4 Financial Overview
  • 19.3 Bio-Rad Laboratories, Inc.
    • 19.3.1 Company Overview
    • 19.3.2 Products And Services
    • 19.3.3 Business Strategy
    • 19.3.4 Financial Overview
  • 19.4 Promega Corporation
    • 19.4.1 Company Overview
    • 19.4.2 Products And Services
    • 19.4.3 Business Strategy
    • 19.4.4 Financial Overview
  • 19.5 OriGene Technologies Inc.
    • 19.5.1 Company Overview
    • 19.5.2 Products And Services
    • 19.5.3 Business Strategy
    • 19.5.4 Financial Overview
  • 19.6 Takara Bio Inc.
    • 19.6.1 Company Overview
    • 19.6.2 Products And Services
    • 19.6.3 Business Strategy
    • 19.6.4 Financial Overview

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

  • 22.1 Tectonic Therapeutic Merged With AVROBIO
  • 22.2 Kyowa Kirin Acquired Orchard Therapeutics
  • 22.3 Syncona Acquired Applied Genetic Technologies Corp.
  • 22.4 Eli Lilly Acquired Akouos
  • 22.5 Eli Lilly Acquired Prevail Therapeutics

23 Opportunities And Strategies

  • 23.1 Global Gene Delivery Technologies Market In 2028 - Countries Offering Most New Opportunities
  • 23.2 Global Gene Delivery Technologies Market In 2028 - Segments Offering Most New Opportunities
  • 23.3 Global Gene Delivery Technologies Market In 2028 - Growth Strategies
    • 23.3.1 Market Trend Based Strategies
    • 23.3.2 Competitor Strategies

24 Gene Delivery Technologies Market, Conclusions And Recommendations

  • 24.1 Conclusions
  • 24.2 Recommendations
    • 24.2.1 Product
    • 24.2.2 Place
    • 24.2.3 Price
    • 24.2.4 Promotion
    • 24.2.5 People

25 Appendix

  • 25.1 Geographies Covered
  • 25.2 Market Data Sources
  • 25.3 Research Methodology
  • 25.4 Currencies
  • 25.5 The Business Research Company
  • 25.6 Copyright and Disclaimer